Jubilant Life Sciences Ltd

Jubilant Life Sciences,is an integrated global pharmaceutical and life sciences company engaged in manufacturing and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products, Advance Intermediates, Fine Ingredients, Crop Science Ingredients, Life Science Chemicals and Nutritional Products.

  • Market Cap: 7,043 Cr.
  • Current Price: 442.25
  • 52 weeks High / Low 639.95 / 230.00
  • Book Value: 351.78
  • Stock P/E: 7.64
  • Dividend Yield: 1.13 %
  • ROCE: 16.37 %
  • ROE: 16.62 %
  • Sales Growth (3Yrs): 16.59 %
  • Listed on BSE and NSE
  • Company Website
  • Face Value: 1.00
Edit ratios
Pros:
Company has good consistent profit growth of 29.67% over 5 years
Cons:
Company might be capitalizing the interest cost
Promoter holding has decreased over last 3 years: -4.57%

Peer comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020
1,556 1,642 2,068 2,252 2,079 2,269 2,377 2,386 2,182 2,266 2,315 2,391
1,219 1,336 1,651 1,794 1,641 1,819 1,884 2,028 1,747 1,797 1,808 1,855
Operating Profit 338 306 417 458 438 450 493 358 435 468 507 537
OPM % 22% 19% 20% 20% 21% 20% 21% 15% 20% 21% 22% 22%
Other Income 7 7 3 23 -12 -5 14 -241 10 12 -29 19
Interest 69 66 77 72 51 54 53 62 73 72 72 71
Depreciation 72 79 82 182 88 89 98 95 103 117 113 129
Profit before tax 203 168 261 227 286 302 356 -40 269 292 293 356
Tax % 29% 25% 19% 33% 30% 30% 25% -152% 31% 15% 31% 27%
Net Profit 147 128 213 155 202 210 261 -99 185 249 203 260
EPS in Rs 9.44 8.23 13.64 9.94 13.00 13.50 16.74 -6.38 11.61 15.66 12.77 16.35
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
2,460 3,485 3,749 3,420 4,270 5,132 5,762 5,751 5,749 5,861 7,518 9,111 9,154
1,994 2,795 3,064 2,854 3,379 4,134 4,763 5,141 4,493 4,510 5,995 7,367 7,207
Operating Profit 466 690 684 565 891 999 999 610 1,256 1,352 1,522 1,744 1,947
OPM % 19% 20% 18% 17% 21% 19% 17% 11% 22% 23% 20% 19% 21%
Other Income 133 96 27 -25 -318 -93 -173 86 4 19 36 -249 13
Interest 39 326 69 120 238 311 337 368 371 341 284 220 287
Depreciation 104 163 125 180 221 254 281 288 347 291 415 371 462
Profit before tax 456 297 518 241 114 341 207 40 542 738 859 904 1,211
Tax % 13% 9% 19% 6% 60% 45% 34% 200% 29% 22% 26% 36%
Net Profit 400 283 421 230 15 153 109 -58 392 576 643 574 898
EPS in Rs 27.14 18.93 26.22 14.10 0.43 9.08 6.53 0.00 25.21 36.96 41.26 36.06 56.39
Dividend Payout % 5% 8% 8% 14% 328% 31% 43% -83% 12% 8% 7% 12%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:10.09%
5 Years:9.60%
3 Years:16.59%
TTM:0.48%
Compounded Profit Growth
10 Years:9.90%
5 Years:29.67%
3 Years:22.93%
TTM:18.07%
Stock Price CAGR
10 Years:2.93%
5 Years:20.96%
3 Years:-15.87%
1 Year:-10.70%
Return on Equity
10 Years:13.20%
5 Years:13.70%
3 Years:17.22%
Last Year:16.62%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
15 15 16 16 16 16 15 16 16 16 16 16 16
Reserves 1,242 1,528 2,185 2,156 2,241 2,460 2,611 2,438 2,951 3,420 4,071 4,793 5,588
Borrowings 2,108 3,942 3,173 3,926 3,818 4,245 4,395 4,793 4,493 4,045 3,469 4,840 4,570
820 1,278 1,450 1,434 1,688 1,650 1,842 1,372 1,280 1,417 1,902 1,670 2,348
Total Liabilities 4,184 6,762 6,825 7,532 7,763 8,371 8,864 8,619 8,740 8,899 9,457 11,319 12,522
1,912 3,745 3,819 3,991 4,460 4,967 5,099 4,911 5,104 5,107 5,401 5,648 6,845
CWIP 485 503 506 667 686 437 472 597 611 684 671 901 264
Investments 46 271 256 33 19 26 34 40 85 103 124 115 69
1,741 2,243 2,244 2,841 2,598 2,941 3,259 3,071 2,939 3,006 3,262 4,654 5,344
Total Assets 4,184 6,762 6,825 7,532 7,763 8,371 8,864 8,619 8,740 8,899 9,457 11,319 12,522

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
257 457 701 390 707 970 772 783 1,099 1,268 1,303 1,122
-1,201 -1,857 -279 -455 -596 -504 -164 -362 -309 -465 -614 -1,018
593 1,252 -298 608 -889 -450 -414 -503 -843 -686 -901 657
Net Cash Flow -351 -148 124 543 -778 17 194 -82 -52 117 -212 761

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 17% 14% 11% 7% 12% 12% 11% 6% 13% 15% 15% 16%
Debtor Days 63 53 50 56 56 50 51 52 60 63 55 51
Inventory Turnover 6.24 6.76 5.83 4.95 4.99 4.80 4.69 4.46 4.72 4.84 5.76 6.49